CNBC Daily Open: China posts better-than-expected economic data

CNBC Daily Open: China posts better-than-expected economic data


Citizens shop at a supermarket in Zaozhuang, China, on October 13, 2024. 

Costfoto | Nurphoto | Getty Images

This report is from today’s CNBC Daily Open, our international markets newsletter. CNBC Daily Open brings investors up to speed on everything they need to know, no matter where they are. Like what you see? You can subscribe here.

What you need to know today

Better-than-expected growth for China
China’s third-quarter gross domestic product expanded by 4.6% year on year, according to the National Bureau of Statistics. Even though that’s higher than the 4.5% in a Reuters poll, it trails the second-quarter’s growth of 4.7%. On a quarterly basis, China’s economy grew by 0.9% in the third quarter.

Chinese and U.S. retail sales going strong
China’s retail sales for September grew 3.2% from a year ago, said the National Bureau of Statistics. That’s better than the 2.5% estimate in an LSEG poll and August’s figure of 2.1%. Across the Pacific Ocean, retail sales in the U.S. rose a seasonally adjusted 0.4% for September. It’s higher than both the 0.1% gain in August and the 0.3% Dow Jones forecast.

Dow bucks the trend to rise
U.S. markets had a mixed Thursday. The Dow Jones Industrial Average added 0.37% to close at another record level. But the S&P 500 and Nasdaq Composite were mostly unchanged. Asia-Pacific markets were mixed Friday. China’s Shanghai Composite rose around 1.5% on positive economic data and a suggestion by Beijing’s central bank governor that it could ease monetary policy further.

An alternative deal for Altera
Intel is looking at a deal to sell its Altera unit for around $17 billion, according to people who requested anonymity to speak about the confidential matter. Just last month Intel CEO Pat Gelsinger said Altera is a core part of Intel’s future. Altera manufactures a type of semiconductor that can be reprogrammed, unlike CPUs.

[PRO] Soaring small caps
Unlike big companies, small companies don’t have the heft to negotiate for low-rate loans, for instance, or the cash moat to withstand fluctuations in consumer habits. Hence, as the U.S. Federal Reserve cuts interest rates, small-cap stocks tend to benefit more. And they have just hit a high not seen in three years.

The bottom line

The Bottom Line is on a break today. Normal programming will resume Monday, Oct. 21, 2024.



Source

H-1B visa applicants face more disruptions amid social media checks and wage protection rules
World

H-1B visa applicants face more disruptions amid social media checks and wage protection rules

H-1B applicants face a challenging year ahead as political pushback to the visas is reinforced with a slew of actions from the U.S. administration. On Monday, the U.S. Embassy in India posted on X that since Dec. 15, it has started conducting online presence reviews of all H-1B and H-4 visa applicants in a bid […]

Read More
What a Russia-Ukraine peace deal could mean for Europe’s gas supplies
World

What a Russia-Ukraine peace deal could mean for Europe’s gas supplies

Europe is pressing ahead with plans to ban Russian gas imports by the end of 2027, effectively capping Moscow’s energy future in the region and leaving a bevy of stranded assets in its wake. The dual Nord Stream 1 and 2 subsea pipelines were early casualties of Russia’s invasion of Ukraine, with the infrastructure being […]

Read More
Shares in Wegovy-maker Novo Nordisk pop 6% after GLP-1 pill approval
World

Shares in Wegovy-maker Novo Nordisk pop 6% after GLP-1 pill approval

Shares in Novo Nordisk surged 6% Monday, after the Wegovy maker secured approval of its GLP-1 pill — a world first. The U.S. Food and Drug Administration’s approval of Novo Nordisk’s GLP-1 pill gives the Danish pharmaceutical giant a head start over U.S. rival Eli Lilly. The pill’s starting dose of 1.5 milligrams will be […]

Read More